Multiple therapeutic targets were mediated by active ingredients of XYS, such as IL2, IL4, IL6, IL10, and STAT3, which are involved in immune and inflammatory responses closely associated with depression. This evidence concerns the gene STAT3 and depressive symptom measurement.